Skip to content
Disclosery

HAYMAN CAPITAL MANAGEMENT, L.P.

Follow

13F filer, CIK 1420192, Dallas, TX

HAYMAN CAPITAL MANAGEMENT, L.P. reported $125,545,000 across 3 holdings for the quarter ended 2016-06-30, in a 13F-HR filed 2016-08-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-16-019916

Period
2016-06-30
Reported value
$126M
Holdings
3
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NMIHreduced-2,058,848-$11.3M
CLOVIS ONCOLOGY INCexited-100,000-$1.92M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2016

Share positions as resolved from 13F-HR 0000950123-16-019916, largest first. % of portfolio is the value over $35,290,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NMIHNMI HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: 5,496,500 shares; 2015Q1: 5,496,500 shares; 2015Q2: 5,496,500 shares; 2015Q3: 7,371,500 shares; 2015Q4: 7,371,500 shares; 2016Q1: 7,371,500 shares; 2016Q2: 5,312,652 shares 5,312,652$29.1M82.5%-2,058,848Timeline
ECO STIM ENERGY SOLUTIONS INECO STIM ENERGY SOLUTIONS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: not reported; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 2,130,000 shares; 2015Q4: 2,130,000 shares; 2016Q1: 2,130,000 shares; 2016Q2: 2,130,000 shares 2,130,000$6.18M17.5%0

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MCDMCDONALDS CORP COMput750,000$90.3Mnew

Sold out in Q2 2016

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CLOVIS ONCOLOGY INCCLOVIS ONCOLOGY INC100,000$1.92Mshares

How Q2 2016 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-16-019916 base2016-08-15acceptance time not in the bulk data set